Presented:

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

Read Now

Presented:

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

Read Now

Presented:

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

Read Now

Presented:

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

Read Now

Presented:

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

Read Now

Presented:

NeoGenomics Announces Leadership Appointments

Read Now

Presented:

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

Read Now

Presented:

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

Read Now

Presented:

Being Comprehensive in Hematologic Malignancies

Presented:

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference

Read Now